Cargando…
Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder
OBJECTIVES: Approximately 40-60% of obsessive-compulsive disorder patients are nonresponsive to serotonin reuptake inhibitors. Genetic markers associated with treatment response remain largely unknown. We aimed (1) to investigate a possible association of serotonergic polymorphisms in obsessive-comp...
Autores principales: | Corregiari, Fábio M, Bernik, Márcio, Cordeiro, Quirino, Vallada, Homero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da
Universidade de São Paulo
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317252/ https://www.ncbi.nlm.nih.gov/pubmed/22522758 http://dx.doi.org/10.6061/clinics/2012(04)06 |
Ejemplares similares
-
The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
por: Sampaio, Thiago, et al.
Publicado: (2016) -
Inhibition of thoughts and actions in obsessive-compulsive disorder:
extending the endophenotype?
por: Morein-Zamir, S., et al.
Publicado: (2010) -
Subcortical and cortical morphological anomalies as an endophenotype in Obsessive-Compulsive Disorder
por: Shaw, Philip, et al.
Publicado: (2014) -
Abnormal Anhedonia as a Potential Endophenotype in Obsessive–Compulsive Disorder
por: Xu, Chuanyong, et al.
Publicado: (2020) -
Fronto-striatal structures related with model-based control as an endophenotype for obsessive–compulsive disorder
por: Kasal, Meltem I., et al.
Publicado: (2021)